The flower buds of Tussilago farfara L. (Compositae) have been traditionally used in Oriental medicine for the treatment of bronchitis and asthma. The extract of T. farfara was reported to exhibit antiinflammatory actions by inhibiting arachidonic acid metabolism and nitric oxide (NO) production in lipopolysaccharide-activated macrophages. In the present study, we investigated the effects of the ethyl acetate (EA) fraction on various types of neuronal cell damage induced in primary cultured rat cortical cells. Its antioxidant activities were also evaluated by cell-free bioassays. We found that the EA fraction potently inhibited the neuronal damage induced by arachidonic acid. We also found that it significantly attenuated the neuronal damage induced by spermine NONOate, a stable NO generator. In addition, it inhibited the A b b (25-35) -induced neurotoxicity and glutamate-or N-methyl-D-aspartic acid-induced excitotoxicity. It was found that the oxidative neuronal damage induced by H 2 O 2 , xanthine/xanthine oxidase, or Fe 2؉ /ascorbic acid was also inhibited by the EA fraction. Furthermore, it was shown to inhibit lipid peroxidation initiated by Fe 2؉ /ascorbic acid in rat brain homogenates, and scavenge DPPH radicals. This is the first demonstration of neuroprotective and antioxidant effects of T. farfara. Although complex mechanisms may be involved in the neuroprotective actions, T. farfara may be useful for the management of neurodegenerative disorders associated with inflammation, A b b , excitotoxicity, and/or oxidative stress.
The flower buds of Tussilago farfara L. (Compositae), also known as "Kwandong Hwa" in Korea and China, have long been used in traditional Oriental medicine for the treatment of bronchitis and asthma. 1) However, only a few pharmacological actions have been demonstrated in vitro and in animals so far. T. farfara was reported to inhibit platelet aggregation by interfering with the binding of platelet activating factor to platelet membranes. 2) In an animal study, it was shown to exhibit cardiovascular-respiratory stimulation. 3) Tussilagone, (7R,14R)-14-acetoxy-7-[(2ЈE)-3Ј-methylpent-2Ј-enoyloxy]-oplopanone, was found to be the active principle exhibiting the pressor effect in animals. 3) More recently, T. farfara has been reported to inhibit arachidonic acid metabolism. 4) Arachidonic acid is known to serve as a substrate for the generation of a variety of inflammatory mediators including prostaglandins, thromboxanes, leukotrienes, and reactive oxygen radicals. Thus, the inhibition of arachidonic acid metabolism by T. farfara may be one of the mechanisms by which it exerts antiinflammatory action. T. farfara has also been reported to inhibit nitric oxide (NO) synthesis in lipopolysaccharide-stimulated macrophages. 5) Overproduction of NO is also strongly implicated in the pathophysiology of inflammatory conditions, and thus, the inhibition of NO production by T. farfara may also contribute to its antiinflammatory action. These findings may provide a basis for the traditional application of T. farfara to treat inflammatory conditions including asthma.
Inflammation has also been widely recognized as a crucial mediator in the etiology of central nervous system (CNS) disorders. The expression of inflammatory mediators including cyclooxygenase enzymes and their products is shown to be increased in many acute and chronic neurodegenerative diseases, and several of these factors are found to contribute directly to neuronal injury. 6) Moreover, excess NO has been viewed as a major agent of neuropathology, by directly or indirectly promoting oxidative and nitrosative stresses. 7) Therefore, antiinflammatory agents and/or inhibitors of NO production are considered to be potentially beneficial for the managements of CNS disorders such as stroke and Alzheimer's disease (AD). 6, 7) In the present study, we attempted to characterize pharmacological actions of T. farfara in the CNS using primary cultured rat cortical cells. According to our preliminary data, the hexane-soluble fraction of T. farfara exhibited cytotoxicity in cortical cells. In contrast, the ethyl acetate (EA)-soluble fraction was not toxic and exhibited antioxidant activity in vitro. Therefore, our study focused on the effects of the EA fraction. Based on the fact that T. farfara inhibits arachidonic acid metabolism, 4) we first examined its effect on the neuronal damage induced by arachidonic acid. For further characterization, the effects on the neuronal damage induced by spermine NONOate (a stable NO generator), A b , glutamate or N-methyl-D-aspartic acid (NMDA), or oxidative stress were also evaluated. In addition, its antioxidant properties were assessed in this study by cell-free bioassays.
MATERIALS AND METHODS
Materials Materials used for cell cultures including minimum essential medium (MEM) and fetal calf serum were obtained from Gibco BRL (Grand Island, NY, U.S.A.). Arachidonic acid, NMDA, L-glutamic acid, xanthine, xanthine oxidase, H 2 O 2 , 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma (St. Louis, MO, U.S.A. The plant material (2 kg) was extracted three times with methanol under reflux, and the combined extracts were concentrated to yield the methanol extract (414 g). The methanol extract was suspended in water and partitioned with n-hexane to remove highly lipophilic components, and further partitioned with EA. The EA fraction (11 g) was used for the evaluation of neuroprotective and antioxidant actions in this study.
Primary Cultures of Rat Cortical Cells Cortical cell cultures containing neuronal and non-neuronal cells were prepared from the cerebral cortices of SD rat embryos at 16-18 d of gestation and maintained as previously described. 8) Proliferation of non-neuronal cells was arrested by the addition of 10 mM cytosine arabinoside at 7 d after plating. 8) All experiments were performed at 10-13 d in vitro.
Treatment of Cells and Assessment of Cell Viability
Cultured cortical cells were washed with HEPES-buffered salt solution (HBSS), and exposed to arachidonic acid (100 mM) or A b(25-35) (40 mM) for 24 h in MEM supplemented with 21 mM glucose as described. 9) Oxidative neuronal damage was induced by exposure to xanthine (0.5 mM)/xanthine oxidase (10 mU/ml) for 10 min, H 2 O 2 (100 mM) for 5 min, or Fe 2+ (100 mM)/ascorbic acid (25 mM) for 2 h in HBSS as described. 10, 11) Excitotoxic damage was induced by the exposure to L-glutamate (100 mM) or NMDA (100 mM) for 15 min in Mg 2+ -free HBSS as described. 12, 13) The cultures were then washed with HBSS and maintained at 37°C for 20-24 h in MEM supplemented with 21 mM glucose.
To evaluate the effects of the EA fraction of T. farfara on the neuronal cell damage induced as described above, the cultures were simultaneously exposed to various concentrations of the test sample during the respective insults. The stock solution of the test sample was prepared in 100% dimethyl sulfoxide (DMSO) at 200-fold the highest concentration tested and then serially diluted to the desired concentrations. For control treatment, sister cultures were exposed to 0.5% DMSO, which showed no effects on cell viability. 8) Following the treatment of cells, cell viability was assessed using MTT reduction assays. 14) In brief, MTT was added to each well at the final concentration of 0.5 mg/ml, and the cells were incubated at 37°C for 3 h. The media were then removed and the formazan crystals produced in the wells were dissolved by the addition of DMSO. The absorbance was measured at 550 nm using a VERSA max microplate reader (Molecular Devices, U.S.A.). Cell viability was calculated using the following formula: cell viability (%)ϭ100ϫ(Abs insultϩsample ϪAbs insult )/(Abs control ϪAbs insult )
In some experiments, the activities of lactate dehydrogenase (LDH) released into the culture media were also measured according to the method previously described 8, [10] [11] [12] [13] to validate the results of the MTT reduction assay. We found that the cell viability assessed by MTT assay and LDH assay exhibited comparable results, as previously reported.
15)

Assay of Lipid Peroxidation in Rat Brain Homogenates
Lipid peroxidation was initiated by Fe 2+ (10 mM) and L-ascorbic acid (100 mM) in rat forebrain homogenates, and assayed as previously described. 16) In brief, the reaction mixture was incubated at 37°C for 1 h in the absence or presence of various concentrations of the test sample. The reaction was stopped by the addition of trichloroacetic acid (28% w/v) and thiobarbituric acid (1% w/v) in succession, and the mixture was then heated at 100°C for 15 min. After centrifugation to remove precipitates, the absorbance was measured at 532 nm. The percent inhibition was calculated using the following formula:
inhibition (%)ϭ100ϫ(Abs control ϪAbs sample )/Abs control Assay for DPPH Radical Scavenging Activity DPPH radical scavenging activity was measured according to the method previously described. 16) Briefly, the reaction mixture containing various concentrations of the test sample and DPPH methanolic solution (150 mM) was incubated at 37°C for 30 min and the absorbance was measured at 520 nm. The percent scavenging activity was calculated using the above formula.
Data Calculation All experiments were performed at least three times in duplicate. Data are expressed as meansϮS.E.M. IC 50 values, 50% inhibitory concentrations, were determined by non-linear regression of the mean values using Prism (GraphPad Software Inc., U.S.A.). Statistical analysis was performed by Student's t-test with a p value of less than 0.05 being considered statistically significant.
RESULTS
Inhibition of Arachidonic Acid-Induced Neuronal
Damage by T. farfara Before we examine the effects of the EA fraction of T. farfara on the neuronal damage, we first tested if the EA fraction itself affects the cell viability of the primary cultured rat cortical neurons maintained for 10-13 d in vitro. It was found that the EA fraction showed no effect on the cell viability in the absence of the insults (Fig. 1) . Since T. farfara has been demonstrated to inhibit arachidonic acid metabolism, we examined its effect on the neuronal damage induced by arachidonic acid. The exposure of cultured cells to 100 mM arachidonic acid for 24 h produced marked neuronal injury. Based on the MTT reduction assay, the arachidonic acid treatment resulted in approximately 60-70% of cells damaged as compared to the vehicletreated control cells. The effect of T. farfara on the arachidonic acid-induced cell damage was evaluated by measuring the cell viability in the presence of various concentrations of the EA fraction. As illustrated in Fig. 1 , the cell viability was dramatically and concentration-dependently increased by the EA fraction, demonstrating potent inhibition of the arachidonic acid-induced damage. The calculated IC 50 value was 0.64 mg/ml.
Inhibition of NO-Induced Neuronal Damage by T. farfara
To evaluate the effect of T. farfara on the damage induced by NO, the cultured cells were exposed to spermine NONOate, a stable complex of NO and spermine known to generate a controlled release of NO in solution. 17) Based on the MTT reduction assay, about 40% of cells were damaged by the exposure to 500 mM spermine NONOate for 24 h. We found that the spermine NONOate-induced cell damage was significantly reduced by the EA fraction. As shown in Fig. 2 , the cell viability was increased to about 30-40% at the concentrations of 10 mg/ml and above. The cultured cells exposed to 1000 mM spermine NONOate exhibited more than 80% of cells damaged, and the damage was also significantly attenuated by the EA fraction (data not shown).
Inhibition of A b b (25-35) -Induced Neuronal Damage by T. farfara In order to characterize additional pharmacological actions in the CNS, we then examined the effect of the EA fraction on the damage induced by A b (25-35) , an active neurotoxic peptide fragment of A b . 18) In consistence with our previous observation, 9) the exposure of the cultured cells to 40 mM A b(25-35) for 24 h generated prominent neuronal cell damage. We found that the A b(25-35) -induced damage was inhibited by T. farfara, exhibiting a concentration-dependent increase in the cell viability (Fig. 3) . The IC 50 value was 30.9 mg/ml.
Inhibition of Excitotoxic Neuronal Damage by T. farfara
We also examined the effect of the EA fraction on the excitotoxic damage induced by glutamate or NMDA in primary cultured cortical cells. In agreement with the previous reports, 13, 16, 19) the exposure of the cultured cells to glutamate or NMDA for 15 min produced marked acute neuronal swelling and ultimately resulted in delayed neuronal death over 20-24 h. We found that the glutamate-or NMDA-induced excitotoxicity was inhibited by the EA fraction, exhibiting concentration-dependent increases in the cell viability (Fig. 4) . The calculated IC 50 values were 76.3 and 53.7 mg/ml, respectively. The cultured cells (10-13 d in vitro) were exposed to the indicated concentrations of the EA fraction prepared from T. farfara in the absence or presence of 100 mM arachidonic acid. Cell viability was assessed after 24 h using the MTT reduction assay as described in Materials and Methods. Each point represents the meanϮS.E.M. from three separate experiments performed in duplicate. * pϽ0.05 vs. the viability of the cells exposed to arachidonic acid in the absence of the test sample.
Fig. 2. Effects of T. farfara on Spermine NONOate-Induced Damage in Primary Cultured Cortical Cells
The cultured cells (10-13 d in vitro) were exposed to 500 mM spermine NONOate for 24 h in the absence or presence of the indicated concentrations of the EA fraction, and cell viability was assessed using the MTT reduction assay. Each point represents the meanϮS.E.M. from three different experiments performed in duplicate. * pϽ0.05 vs. the viability of the cells exposed to spermine NONOate in the absence of the test sample. Inhibition of Oxidative Stress-Induced Neuronal Damage by T. farfara To evaluate the effects of the EA fraction on various types of oxidative neuronal damage, cultured cells were exposed to H 2 O 2 , xanthine/xanthine oxidase, or Fe 2+ /ascorbic acid. Consistent with our previous findings, 10, 11, 16) approximately 60-90% of cells were damaged after 20-24 h of the oxidative insults. In this study, we found that the oxidative stress-induced damage was significantly inhibited by the EA fraction. As illustrated in Fig. 5 , the viability of the cells exposed to Fe 2+ /ascorbic acid was increased most potently, in which a 50% increase was achieved at 18.1 mg/ml. Moreover, the inhibition was highly effective, since almost 90% of cells were protected from the Fe 2+ /ascorbic acid-induced damage (Fig. 5 ). In contrast, the H 2 O 2 -induced damage was not significantly inhibited until the concentration was increased to 300 mg/ml. The viability of the cells exposed to xanthine/xanthine oxidase was moderately increased by the EA fraction at concentrations of 30 mg/ml and above (Fig. 5) .
Inhibition of Lipid Peroxidation by T. farfara and Its DPPH Radical Scavenging Activity We finally examined antioxidant properties of the EA fraction using cell-free bioassays. The EA fraction of T. farfara potently inhibited lipid peroxidation initiated by Fe 2+ and ascorbic acid in rat brain homogenates (Fig. 6) , with the IC 50 value of 6.3 mg/ml. In addition, it was shown to potently scavenge DPPH free radicals (Fig. 7) . Fifty percent scavenging activity was achieved at 14.3 mg/ml.
DISCUSSION
In this study, we present novel pharmacological actions of T. farfara. The EA fraction prepared from the flower buds of T. farfara was shown to protect primary cultured rat cortical cells from various types of neuronal cell damage. In addition, it inhibited lipid peroxidation in rat brain homogenates and scavenged DPPH radicals. Although several pharmacological actions of T. farfara have been reported previously, this is the first report demonstrating its antioxidant and neuroprotective effects in the nervous system.
Based on the fact that T. farfara exerts antiinflammatory action by inhibiting arachidonic acid metabolism, 4) we first determined whether it inhibits neuronal cell damage induced by arachidonic acid in cultured cortical cells. The arachidonic acid-induced damage was found to be potently and efficaciously inhibited by T. farfara (Fig. 1) . The IC 50 value was 0.64 mg/ml, and approximately 75% of cells were protected from the damage at concentrations of 3 mg/ml and above. These findings imply that T. farfara may exert antiinflammatory action in the CNS as well, and therefore, it may be beneficial in the treatment of CNS disorders associated with inflammation.
In addition to arachidonic acid, inflammatory mediators including NO play crucial roles in the development of many neurodegenerative diseases.
6,7) Thus, we next investigated whether T. farfara protects neuronal cells from the damage induced by NO. Although the inhibition was not as dramatic as that of the arachidonic acid-induced damage, the EA fraction was found to significantly attenuate the NO-induced damage (Fig. 2) . T. farfara was previously reported to inhibit NO production in macrophages by inhibiting the expression The cultured cells (10-13 d in vitro) were exposed to H 2 O 2 (100 mM) for 5 min, xanthine (0.5 mM)/xanthine oxidase (10 mU/ml) for 10 min, or Fe 2+ (100 mM)/ascorbic acid (25 mM) for 2 h in the absence or presence of the indicated concentrations of the EA fraction, and cell viability was assessed using the MTT reduction assay after incubation for 20-24 h at 37°C. Each point represents the meanϮS.E.M. from at least three different experiments performed in duplicate. * pϽ0.05 vs. the viability of the cells exposed to the respective oxidative insults in the absence of the test sample. of inducible NO synthase (iNOS) rather than directly inhibiting the enzyme activity.
5) It would be interesting to investigate whether it inhibits NO production in glia by the same mechanism as in macrophages.
To determine additional central actions of T. farfara, we then examined its effects on the neuronal damage induced by various types of insults, such as A b , oxidative stress, and excitotoxic amino acids, all of which are believed to be crucial causative factors in neurodegenerative disorders. A b peptides are believed to be one of the major factors in AD. 20) Although the precise mechanisms mediating A b toxicity remain to be fully elucidated, the toxicity is suggested to be associated with increases in reactive oxygen species (ROS), which may in turn initiate neurotoxic events leading to oxidative cellular damage and subsequent neuronal cell death. 21) We found in this study that T. farfara inhibited the A b (25-35) -induced neuronal damage (Fig. 3) . At this point, however, the mechanisms by which the EA fraction inhibits the A b toxicity is not fully understood. Since the EA fraction was also found to significantly increase the viability of cells exposed to various types of oxidative stress (Fig. 5) , it is possible that the inhibition of oxidative damage may contribute, at least in part, to its protective action against the A b toxicity. Emerging evidence suggests that endoplasmic reticulum (ER) stress and activation of caspase 12 seem to be involved in the A b toxicity. 22) Thus, it will be worth examining the effects of the EA fraction on ER stress to elucidate its action mechanisms.
Oxidative stress such as H 2 O 2 , xanthine/xanthine oxidase, or Fe 2+ /ascorbic acid generates free radicals such as hydroxyl and superoxide radicals, which are believed to actively participate in the initiation of lipid peroxidation and eventually cause cell death. 11, 23) Among the oxidative stresses used in this study, the Fe 2+ /ascorbic acid-induced damage was inhibited most potently and efficaciously, whereas the inhibition of the H 2 O 2 -or xanthine/xanthine oxidase-induced damage was less effective (Fig. 5) . Based on our findings that H 2 O 2 and xanthine/xanthine oxidase induced more profound neuronal damage (90%) than Fe 2+ /ascorbic acid (60%), different degrees of inhibition may partly be due to the different extent of oxidative damage produced by the respective insults.
T. farfara was found to inhibit lipid peroxidation (Fig. 6 ) and scavenge DPPH radicals (Fig. 7) , confirming its antioxidant actions. Considering that brain tissue is known to be particularly susceptible to oxidative damage, and that various types of oxidative stress play pivotal roles in the pathogenesis not only of AD but also of a number of acute and chronic neurodegenerative disorders including stroke, 21, 23) these findings imply the potential roles of T. farfara in the management of such disorders.
L-Glutamate is the principal excitatory amino acid neurotransmitter in the mammalian central nervous system. Accumulating evidence indicates that excessive release of glutamate is also known to be a major cause for neuronal damage in many neurodegenerative disorders. 24) Overstimulation of glutamatergic receptors such as NMDA subtype provokes neurotoxic mechanisms including the production of ROS, eventually resulting in cell death by oxidizing cellular components such as lipids, proteins, and DNA. 25) In this study, we additionally found that T. farfara protected cortical cells against the excitotoxicity induced by glutamate or NMDA.
Taken together, the present study demonstrates the antioxidant and neuroprotective effects of T. farfara. The EA fraction was shown to inhibit lipid peroxidation, scavenge DPPH radicals, and inhibit various types of neuronal cell damage induced in the primary cultured rat cortical cells. These results provide novel pharmacological actions of T. farfara in the CNS, and suggest that it may be useful for the management of neurodegenerative disorders associated with inflammation, A b , excitotoxicity, and/or oxidative stress. Future study will be focused on identification of the active principle(s) in the EA fraction and characterization of its action mechanism(s). Several sesquiterpenoids and phenolic compounds have been reported from this plant. [26] [27] [28] It would be interesting to investigate whether these compounds exhibit neuroprotective and antioxidant activities.
